These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29436791)

  • 1. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer.
    Kim SJ; Tae CH; Hong SN; Min BH; Chang DK; Rhee PL; Kim JJ; Kim HC; Kim DH; Kim YH
    Mol Carcinog; 2015 Dec; 54(12):1748-57. PubMed ID: 25620232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia.
    Osborn NK; Zou H; Molina JR; Lesche R; Lewin J; Lofton-Day C; Klatt KK; Harrington JJ; Burgart LJ; Ahlquist DA
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):212-8. PubMed ID: 16469682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Bone Morphogenetic Protein 3 Methylation in Iranian Patients with Colorectal Cancer.
    Houshmand M; Abbaszadegan MR; Kerachian MA
    Middle East J Dig Dis; 2017 Jul; 9(3):158-163. PubMed ID: 28894518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
    Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
    Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ; Feng ZC; Li XR; Hu G
    World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
    Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
    Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASGRF1 Hypermethylation, a Putative Biomarker of Colorectal Cancer.
    Chen H; Xu Z; Yang B; Zhou X; Kong H
    Ann Clin Lab Sci; 2018 Jan; 48(1):3-10. PubMed ID: 29530990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
    BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
    Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
    BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.